多汗手汗及ETS後遺症

 

16-05."手汗症ETS交感神經切除應被禁止" 白皮書　作者：王群光醫師


16-05-01.我與交感神經切除術後遺症第一類接觸 

16-05-02.交感神經切除術應被禁止王群光醫師

16-05-03.交感神經系統簡介瑞典網站原文翻譯

16-05-04.自律神經失調對器官的作用

16-05-05.交感神經切除術的起源瑞典網站原文翻譯

16-05-06.手汗症簡介

16-05-07.自律神經所管轄控制之組織器官

16-05-08.手汗交感神經切除術的手術部位

16-05-09.交感神經切除術的副作用王群光醫師

16-05-10.如何以自然療法治療手汗

16-05-11.美國胸腔外科醫師協會對ETS的看法

16-05-12.交感神經切除的副作用

16-05-13.ETS交感神經切除術摧毀了我的生命

16-05-14.ETS交感神經切除術患者大部份都會反射性出汗

16-05-15.它(ETS)是一個恐怖的夢饜

16-05-16.別讓醫師毀了你的神經系統─ETS

16-05-17.交感神經切除術毀掉性生活

16-05-18.其他參考連接網站

 

(點擊上方圖片進入王群光自然診所官網) 

高壓氧醫學文獻彙集

   

癌症患者H2+O2每天必須吸多久？才能阻止癌細胞生長蔓延? 

A 潛水醫學(香港潛水醫學及高壓氧醫學中心)

    1.潛水醫學的歷史
    2.潛水物理學
    3.潛水生理學
    4.潛水病理學
    5.常見潛水疾病急救
    6.高壓氧治療與潛水醫學的關係
    7.潛水醫學研究新進展

B 高壓氧醫學(香港潛水醫學及高壓氧醫學中心)

    1.高壓氧醫學簡介
    2.高壓氧對人體有什麼作用？
    3.高壓氧治療的幾個基本原理 - Life without
       blood
    4.高壓氧治療感染性疾病
    5.高壓氧能否提高組織氧貯備？
    6.高壓氧與缺氧 Hyperbaric oxygen & Hypoxia
    7.高壓氧與缺氧  臨床上缺氧類型
    8.人體對氧的儲存能力差 那麼高壓氧是否能
       夠提高組織氧貯備？
    9.減壓程序理論的起源及其歷史
    10.高壓氧治療的適應症
    11.實證醫學與臨床高壓氧治療的發展現況
    12.現時臨床高壓氧治療中實證醫學的應用
    13.如何選擇合適的高壓氧治療?

 

C 高壓氧醫學需知(彰化秀傳醫院)

    1.認識高壓氧治療
    2.高壓氧治療的適應症
    3.接受高壓氧治療應注意事項
    4.氧生之道
    5.高壓氧治療壞死性筋膜炎
    6.骨髓炎與高壓氧治療
    7.淺談一氧化碳中毒
    8.糖尿病足養生之道
    9.放射線骨壞死與高壓氧治療
    10.缺氧性腦病變
    11.高壓氧治療對腔症候群的神奇療效
    12.燒燙傷的福音

D 高壓氧治療摘要 - 基本原理
   高壓氧治療摘要 - 禁忌與副作用
   高壓氧治療摘要 - 適應症
   高壓氧治療摘要 - 中風 腦麻 多發性硬化症
   高壓氧治療摘要 - 自閉症
   高壓氧治療摘要 - 溶解型氧氣
   高壓氧治療摘要 - 無血液的生命

E 高壓氧QA(網路)
    1.何謂高壓氧?
    2.高壓氧治療一次要多少錢?
    3.爸爸突然中風，請問高壓氧適用於腦中風嗎？
       會有什麼後遺症？爸爸的狀況是右半身麻痺無力，意識
       清醒，口齒不清
    4.何謂高壓氧治療?
    5.高壓氧可以「活膚抗老」是真的嗎？為什麼？
    6.用氧氣助入頭皮毛囊，這可以幫助我家禿頭的老公嗎?
    7.請問高壓氧美容是否真的有療效!?

F 高壓氧衛教資料
    1.公車輾腳瀕截肢  高壓氧治療保住
    2.菸酒不離身 眼睛中風險失明
    3.骨頭也會細菌感染！34歲男骨折引骨  
    4.踩破蝸牛殼 糖尿病患傷口壞死
    5.高壓氧 降腦傷後遺症
    6.高壓氧治療 大幅減輕糖尿病足截肢比例
    7.植牙也用高壓氧？牙醫師：別懷疑！
    8.修復壓瘡  高壓氧和養肉機成尖兵
    9.糖尿病足與高壓氧治療
    10.燒燙傷與高壓氧治療
    11.腦中風與高壓氧治療
    12.突發性耳聾與高壓氧治療
    13.壓挫傷與高壓氧治療
    14.高壓氧治療效益
    15.高壓氧治療的適應症
    16.高壓氧治療禁忌症

 G 氫氣也有療效?

中國學者引領“氫氣醫療” 飲飽和氫氣水望治腫瘤
生命世界：讓人著迷的氫
生命科學領域回顧
生命中的緩衝現象
正確認識活性氧，提倡科學抗氧化
關於氫分子醫學的圖書
氫氣可治療耳聾 
氫氣—從潛水呼吸氣到綠色藥物
氫分子醫學的新啟示：一些臨床藥物的奇怪作用 
氫氣治療大鼠心肌梗死
氫氣治療結腸炎
氫氣（來自腸道細菌）可保護肝炎 
促進氫產生的食物成分 
氫氣與一氧化碳聯合應用於心臟體外器官保護 
氫氣可以預防和治療放射損傷 
氫氣治療小腸缺血再灌注損傷後細胞凋亡 
氫氣鹽水真神！ 
孫學軍醫師的研究：氫分子醫學
氫原子水也是理想的抗氧化物質
氫分子醫學革命
廣告也要講科學：從電解水的作用談起
氫氣生物醫學概述
氫氣鹽水真神
氫氣分子醫學文獻匯總
氫氣是電解水治療疾病的真正原因 
氫氣治療疾病研究進展（日本綜述） 
氫氣生物學研究有可能獲得諾貝爾獎
氫氣是新的具有潛在臨床應用價值的氣體
富氫氣中性電解水的生物安全性或基因毒性實驗
氫氣分子醫學熱點論文介紹
氫氣生物學文獻導讀
新型含氫氣透析液
氫氣通過調節氧化還原酶發揮作用 
氫氣是新的鎮痛物質 
氫氣生物學導讀 
氫氣將對人類健康產生重大影響 
氫氣與健康-前言 
氫氣的神奇醫學作用 
氫為什麼那麼牛？ 
氫氣能治療精神分裂症 
呼吸少量氫氣能有效治療腦創傷，改善腦功能 
氫氣對新生兒窒息後腦損傷有保護作用 
氫鹽水對大鼠酒精性肝損傷的保護作用 
氫共同呼吸可以對抗新生兒七氟烷麻醉後腦損傷  
氫氣可減輕腫瘤壞死因子誘導的成骨細胞損傷 
氫氣水可預防卵巢切除後骨質疏鬆 
氫水能解酒嗎 
氫氣對抗輻射性皮膚損傷
氫氣生物醫學概述 
氫氣和一氧化碳結合用於體外器官保護是最佳搭配  
高壓氫氣治療皮膚鱗狀細胞癌的研究
高壓氫氣治療肝寄生蟲的研究
高壓氧預適應對肝切除的影響
氫氣水治療慢性乙肝的臨床研究
氫氣生理鹽水對脊髓缺血的治療作用  
氫氣水治療代謝綜合徵的臨床研究（中國） 
氫氣選擇性抗氧化作用的發現
一種具有治療缺血再灌注損傷功能的含氫注射液  
氫氣可治療支氣管哮喘
氫氣治療慢性氧中毒
氫氣是電解水治療糖尿病的關鍵原因
氫氣將對人類健康產生重大影響 
氫氣通過抗​​炎症作用治療心肌缺血再灌注損傷 
氫氣對神經系統炎癥損傷治療
氫氣醫學 
產學合作 氫包裝水問世
氫水還原健康-氫氣治療小腸移植後炎症損傷 
氫水還原健康-氫氣可治療膿毒症  
氫分子(H2)可改善各種病症
氫水還原健康-氫氣治療多器官功能衰竭 
氫氣的抗皺美容效果研究
氫氣可治療心臟移植後損傷
氫水還原你健康--氫水能解酒嗎?
"氫水"還原健康:中性電解水的生物安全性或基因毒性實驗

   

 (點擊上方圖片進入王群光自然診所官網)

 

過敏自然醫學

   
這是一本我的著作，在此與大家分享
書名：不吃藥，過敏才會好
第一章：我如何與過敏自然療法結緣
第二章：過敏斷根細胞療法成形的來龍去脈
第三章：三十年醫師生涯恍如黃粱一夢
第四章：不只是您，過敏正全大球流行
第五章：十大延遲性過敏食物排行榜
第六章：自然醫學疾病觀：亞健康三大地雷
第七章：過敏免疫失調災難的源頭
第八章：免過敏疫失調之成因及解套
第九章：先天與後天性免疫力
第十章：腸漏症之成因診斷治療
第十一章：呼吸道也會“漏”
第十二章：淋巴球的武器系統IgE、IgG功能評比
第十三章：細胞療法簡介
第十四章：細胞療法的生化機轉
第十五章：多醣體缺乏導致免疫功能失調疾病
第十六章：過敏及免疫失調4R贏的策略
第十七章：媽媽如何不生出過敏兒
第十八章：你絕對可以跟類固醇說再見
第十九章：拆穿EPADHA的謊言
   

 (點擊上方圖片進入王群光自然診所官網)
 
x

腹腦資料彙集

   

 (點擊上方圖片進入王群光自然診所官網)

王群光自然診所：台北市羅斯福路三段271號10樓

諮詢電話：886-2-23671086

LINE ID：0919730053

 Wechat ID： a0919730053

1. 「腹腦」概念的發韌、演變、內涵及重要性
2. 必須瞭解的腸道知識
3. a. 腸道是性命之祖，生氣之源
4. b. 會思考，有情緒的第二大腦-腹腦
5. c. 腹腦與心理疾病關係密切
6. d. 免疫最前線-腸道
7. 腸道是身體的一面鏡子
8. 藏在肚子裡的第二大腦？
9. 人的第二個大腦-腹腦
10. 情緒原來由腸道掌控
11. 頭腦、心腦、腹腦為生命之支柱
12. 胃腸不好，易多夢失眠
13. 腹腦理論有助解釋腸躁症病因
14. 胃腸不好易焦慮、憂鬱、作惡夢
15. 經由健全腸道(腹腦)可治癒自閉症
16. 雙健全腹腦可避免過勞死
17. 人在生氣時會胃痛，腹腦也擁有智慧
18. 腹腦有智慧，也會生病
19. 失眠與腸胃道之間的關係
20. 腹腦的情緒與健康
21. 腹腦的威力
22. 腹腦-小腸是抗癌大本營
23. 中醫學如何看待慢性胃腸病
24. 春天，善待你的腹腦
25. 七種壞習慣有損大腦健康
26. 腹型癲痢是什麼
27. 人類還有一個腹腦？
28. 藏在肚子裡的第二大腦
29. 腦行為科學(認知神經心理學)-腦和行為的關係
30. “人體第二大腦-腹腦”與“丹田學說”
31. 腸道內經的評論
32. 腸命百歲
33. 人有三個相對獨立的腦 - 腹腦、心腦、頭腦
34. 「腹腦」概念之起源及發展
35. 腹腦的成員及功能評估
36. 腹腦、心腦、頭腦的互動關係與自律神經失調
37. YouTube:過敏斷根細胞療法原理及成果
38. 到診所掛號就診的前置準備工作

   

 (點擊上方圖片進入王群光自然診所官網)

 

生物、磁場、電磁場、腦波彙集

   

 (點擊上方圖片進入王群光自然診所官網)

王群光自然診所：台北市羅斯福路三段271號10樓

諮詢電話：886-2-23671086

LINE ID：0919730053

 Wechat ID： a0919730053

1. 動物昆蟲會先知道自然界大災難來臨前兆的原因為何?

1. 鴿子歸巢性的探討

1. 生物體內的磁石是如何指引方向?

1. 鴿子歸巢的秘密

1. 山區、平原競翔與磁鐵、鴿眼的差異

1. 賽鴿導航之迷

1. 高水準信鴿迷路 疑因地震破壞磁場所致

1. 和平鴿的由來

1. 雁行理論的內涵與啟示-團隊合作、輪流領導、激勵同伴和互相扶持

1. 超心理科技之腦波與心靈改革

   

 (點擊上方圖片進入王群光自然診所官網)

 

「梅尼爾氏症是過敏性疾病」相關學術文獻彙集

1. The role of allergy in Meniere's disease.
2. Allergic and immunologic aspects of Meniere's disease.
3. Allergic management of Meniere's disease: an outcome study.
4. Provocation of endolymphatic hydrops with a prick test in Meniere's disease.
5. Allergic and immunologic features of Ménière's disease.
6. Etiology, pathophysiology of symptoms, and pathogenesis of Meniere's disease.
7. Ménière's syndrome and allergy.
8. Endolymphatic hydrops in asymptomatic ears in unilateral Ménière's disease.
9. Inhalant allergy and Meniere's disease: Use of electrocochleography and intranasal allergen challenge as investigational tools.
10. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?
11. Meniere's disease: evidence of an immune process.
12. Allergy and Ménière's disease.
13. A subpopulation of Menière's patients produce antibodies that bind to endolymphatic sac antigens.
14. Immuno-pathogenesis in Meniere's disease.
15. Allergy and its relation to Meniere's disease.
16. Meniere's disease and endolymphatic hydrops without Meniere's symptoms: temporal bone histopathology.
17. Perilymphatic fistula and Meniere's disease. Clinical series and literature review.
18. Use of electrocochleography for assessing endolymphatic hydrops in patients with Lyme disease and Ménière's disease.
19. Demonstration of autoantibodies to the endolymphatic sac in Meniere's disease.
20. Use of electrocochleography to monitor antigenic challenge in Menière's disease.
21. Pathogenesis of Menière's disease.
22. Meniere's attacks occur in the inner ear with excessive vasopressin type-2 receptors.
23. ence of autoantibodies in the sera of Meniere's disease.
24. History of Meniere's disease and its clinical presentation.
25. Summating potential and action potential ratio in Meniere's disease before and after treatment.
26. Brain and inner-ear fluid homeostasis, cochleovestibular-type tinnitus, and secondary endolymphatic hydrops.
27. Autoimmune reactivity in Ménière's disease: a preliminary report.
28. Antibodies of type II collagen and immune complexes in Menière's disease.
29. Immunological pathogenesis of endolymphatic hydrops and its relation to Menière's disease.
30. A diagnostic test for Ménière's Disease and Cochlear Hydrops: impaired high-pass noise masking of auditory brainstem responses.
31. Imaging of Meniere's disease.
32. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study.
33. Cochlear implantation in patients with bilateral Ménière's syndrome.
34. Evaluation of the effect of streptomycin perfusion of the labyrinth in the treatment of Meniere's disease and endolymphatic hydrops.
35. Plain radiological findings in Ménière's disease.
36. The importance of IgG auto-antibodies, anti- collagen type II specific in Menière's disease and progressive hearing loss.
37. Allergy in Ménière's disease related fluctuating hearing loss preliminary findings in a double-blind crossover clinical study.
38. Serum antibodies against heat shock protein 70 in Menière's disease.
39. Diagnosis of cochlear Ménière's disease with electrocochleography.
40. Etiology and treatment of fluid retention (hydrops) in Ménière's syndrome.
41. Immunoperoxidase study of the endolymphatic sac in Menière's disease.
42. Meniere's disease: prevalence of contralateral ear involvement.
43. Sensory cell damage in two-phase endolymphatic hydrops: a morphologic evaluation of a new experimental model by low-voltage scanning techniques.
44. Serum antibodies to type II collagen and immune complex in cases of Menière's disease.
45. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
46. Endolymphatic sac enhancement surgery in elderly patients with Ménière's disease.
47. Immunological responses in acute low-tone sensorineural hearing loss and Ménière's disease.
48. Ménière's disease.
49. Aldosterone assessment in patients with Menière's disease.
50. Meniere's disease: overview, epidemiology, and natural history.
51. Visualization of endolymphatic hydrops in patients with Meniere's disease.
52. Results of labyrinthectomy in the treatment of Menière's disease and delayed endolymphatic hydrops.
53. Immune mechanisms in Meniere's syndrome.
54. HSP70 antibodies in 80 patients with "clinically certain" Meniere's disease.
55. The basic science of Meniere's disease and endolymphatic hydrops.
56. In reference to visualization of endolymphatic hydrops in patients with Meniere's disease.
57. Immunoglobulin E and circulating immune complexes in endolymphatic hydrops.
58. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
59. Alternobaric oxygen therapy in long-term treatment of Ménière's disease.
60. Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: a long-term follow-up and randomized controlled study.
61. Angioneurosis in Menière's disease.
62. Menière's disease: an immune complex-mediated illness?
63. Immune-mediated sensorineural hearing loss.
64. Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops.
65. The exacerbation of symptoms in Menière's disease during the premenstrual period.
66. Vestibular type of Mondini anomalies with BPPV and Meniere's disease-like symptoms.
67. Delayed endolymphatic hydrops.
68. Antidiuretic hormone (ADH) and endolymphatic hydrops.
69. Immunological aspects of Menière's disease.
70. Depersonalization, vertigo and Ménière's disease.
71. Prevalence of allergy in Meniere's disease.
72. Contemporary perspectives on the pathophysiology of Meniere's disease: implications for treatment.
73. Meniere's disease and allergy: allergens and cytokines.
74. Electrocochleographic changes after intranasal allergen challenge: A possible diagnostic tool in patients with Meniere's disease.
75. Detection of antibody to sialyl-i, a possible antigen in patients with Meniere's disease.
76. Three-dimensional Fourier transformation constructive interference in steady state magnetic resonance imaging of the inner ear in patients with unilateral and bilateral Menière's disease.
77. Prevalence of heat shock protein in patients with Meniere's disease and allergy.
78. The syndrome of physical or intrinsic allergy of the head; vasomotor rhinitis and the vasodilating pain syndrome, their relationship to myalgia and endolymphatic hydrops (Ménière's disease) and the reasons for including all four as the syndrome of physical allergy of the head.
79. Obstructing lesions of the endolymphatic sac and duct mimicking Ménière's disease.
80. Antibodies to inner ear antigens in Meniere's disease.
81. Stress and symptoms of Menière's disease: a time- series analysis.
82. Ménière's disease review 2005.
83. Evaluating quality of life after endolymphatic sac surgery: The Ménière's Disease Outcomes Questionnaire.
84. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière's disease--a clinical multicentre placebo-controlled study.
85. Surgical observations on the endolymphatic sac in Meniere's disease.
86. Transtympanic gentamicin perfusion for the treatment of Meniere's disease.
87. Meniere's disease: the incidence of hydrops in the contralateral asymptomatic ear.
88. Psychological characteristics of patients with Ménière's disease compared with patients with vertigo, tinnitus, or hearing loss.
89. Post-traumatic hydrops.
90. The clinical study of immune factors relative to Menière's disease.
91. The cervicogenic otoocular syndrome: a suspected forerunner of Ménière's disease.
92. Meniere's disease.
93. Immunologic and serologic testing in patients with Ménière's disease.
94. Proto-oncogene Raf-1 as an autoantigen in Meniere's disease.
95. Allergy and Meniere's disease: a review.
96. The discovery of the pathogenesis of Menière's disease.
97. Provocation of nystagmus and deviation by type I allergy in the inner ear of the guinea pig.
98. Hypothesis: could Meniere's disease be a channelopathy?
99. Anti-heat shock protein 70 antibodies in Meniere's disease.
100. Hypofibrinolysis in Menière's disease. Preliminary report.
101. Combined vestibular neurectomy and endolymphatic sac shunt via the retrosigmoid approach in the treatment of Ménière's disease.
102. Distribution and density of subepithelial collagen in the endolymphatic sac in patients with Meniere's disease.
103. Menière's disease and autoimmunity: clinical study and survey.
104. On pathogenesis of symptoms in Ménière's disease.
105. Patients' subjective evaluations of quality of life related to disease-specific symptoms, sense of coherence, and treatment in Ménière's disease.
106. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease.
107. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin.
108. Aquaporins and Meniere's disease.
109. HLA antigens in the pathogenesis of Menière's disease.
110. Endolymphatic sac-vein decompression for intractable Meniere's disease: long term treatment results.
111. Postural control and glycerol test in Ménière's disease.
112. Menière's disease: evolution of a definition.
113. The role of allergy in fluctuating hearing loss.
114. Allergy for the otologist. External canal to inner ear.
115. Is recurrent loss of low frequency tone perception --without vertigo--a precursor of Meniere disease?.
116. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
117. Diagnosis of Meniere's disease: routine and extended tests.
118. Perilymphatic and endolymphatic pressure in the guinea pig after distal dissection of the endolymphatic sac.
119. Vestibular nerve section in a child with intractable Menière's disease.
120. Electrocochleography in patients with Meniere's disease.
121. Use of a screening RAST in a large neuro-otologic practice.
122. Endolymphatic mastoid shunt versus endolymphatic sac decompression for Ménière's disease.
123. External aperture of the vestibular aqueduct in Meniere's disease.
124. Serum antidiuretic hormone levels in patients with unilateral Meniere's disease.
125. Immunologic abnormality in Menière's disease.
126. Diameter of the cochlear nerve in endolymphatic hydrops: implications for the etiology of hearing loss in Ménière's disease.
127. Histopathologic changes of contralateral human temporal bone in unilateral Ménière's disease.
128. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
129. Electrocochleography in the diagnosis of Meniere's disease.
130. Medical management of Meniere's disease.
131. Co-morbidity of migraine and Ménière's disease -- is allergy the link?
132. Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease?
133. Relationship of the cochlear aqueduct and inner ear pressure in Ménière's disease and in a normal population.
134. Aquaporins as potential drug targets for Meniere's disease and its related diseases.
135. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
136. An update on the surgical treatment of Ménière's diseases.
137. Ménière's disease.
138. Definition, classification and reporting of Menière's disease and its symptoms.
139. Electrocochleography and gentamicin therapy for Ménière's disease: a preliminary report.
140. Clinical characteristics of tinnitus in Ménière's disease.
141. Etiopathogenesis of Meniere's disease: a hypothesis.
142. Natural history of Menière's disease: staging the patients or their symptoms?
143. Circulating auto-antibodies in Ménière's disease.
144. The classification and treatment of Menière's disease.
145. Meniere's disease study: three-year progress report.
146. The inter-relationship of vertigo and stress.
147. Type II collagen autoimmunity in otosclerosis and Meniere's Disease.
148. Ménière's disease as a form of cranial polyganglionitis.
149. The choice of the method for treating patients with Menière's disease and similar diseases.
150. Allergic factors in Meniere's disease.
151. Menière's disease: etiology and natural history.
152. Antigenic excitation in Meniere's disease.
153. Meniere's disease and allergy, with special reference to immunoglobulin E and IgE antibody (reagin) in serum.
154. Type II collagen autoimmunity and Ménière's disease.
155. Immune status in patients with Menière's disease.
156. Meniere's disease: update of etiopathogenetic theories and proposal of a possible model of explanation.
157. Evidence of persistent viral infection in Menière's disease.
158. Hyperlipoproteinemia, hyperinsulinism, and Meniere's disease.
159. Contribution to the therapy of Menière's disease (author's transl).
160. Ménière's disease.
161. Allergic backgrounds of Meniere's disease.
162. The significance of the human endolymphatic sac and its possible role in Menière's disease.
163. Value of immunobiological tests in Menière's disease and in rapidly progressive sensorineural deafness.
164. Vertigo and autoimmunity.
165. Pathophysiology of Menière's disease.
166. Ménière's disease; endolymphatic hydrops.
167. Allergic management of Meniere disease.
168. Molecular and cellular pathology of Meniere's disease.
169. Symposium: management of Ménière's disease. 3. Medical management of endolymphatic hydrops.
170. Some remarks on the patient suffering from Méniére's disease.
171. Meniere's disease might be an autoimmune condition?
172. Pathophysiologic theories in the etiology of Meniere's disease.
173. A preliminary study on the mechanism of immune injury of Menière's disease--type V collagen play the role of antigen.
174. Allergy in relation to Meniere's syndrome, labyrinthitis, and headache.
175. Menière's disease: allergy, immunology, psychosomatic, hypo- and hypertonus.
176. Staging Meniere's disease (or any inner ear dysfunction) and the use of the vertigogram.
177. Diagnosis and treatment of endolymphatic hydrops (Ménière's disease).
178. Ablation of luteal phase symptoms of Menière's disease with leuprolide.
179. Advance study in the etiology of Menière's disease.
180. The management of tinnitus with or without Menière's disease.
181. Relationship between immune complex and total hemolytic complement in endolymphatic hydrops.
182. Garlic food allergy with symptoms of Ménière's disease.
183. No increased serum levels of antifood antibodies in patients with Ménière's disease.
184. The characteristics and natural history of tinnitus in Meniere's disease.
185. Psychosomatic aspects of Menière's disease.
186. Autoimmune Menière's disease: current concept.
187. Menière's disease and tinnitus.
188. Allergic therapy for Meniere's disease.
189. Ménière's attacks associated with facial paralysis.
190. Essay on the pathogenesis of Meniere's vertigo.
191. The value of nausea and vomiting due to Ménière's disease--a theory.
192. The natural history of the vertigo component of Meniere's disease.
193. Hydrops of labyrinth (Ménière's disease); diagnosis; results of labyrinth surgery.
194. Ménière's disease and plasmatic hyperosmolarity.
195. Allergic basis of Menière's disease.
196. Dynamics of various blood electrolytes in patients with Menière's disease after desiccation.
197. Pros and cons in the allergic theory of Meniere's disease.
198. Menière's disease. Etiology, natural history, and results of treatment.
199. The diagnosis and evaluation of allergic disorders with food intolerance in Meniere's disease.
200. Medical treatment of Menière disease (author's transl).
201. Terminal otosclerosis with the appearance of Menière's disease.
202. The allergic reactivity of the body in Meniere's disease.
203. Association of gastro-duodenal lesions with Ménière's syndrome.
204. Immunohistochemistry of the Scarpa's ganglion and the crista ampullaris of patients with Menière disease.
205. Predominance of left ear in Meniére's disease, sudden deafness, inner ear damage, tinnitus and abnormally patent eustachian tube.
206. [Trigeminal paralysis in Meniere's disease].
207. Fungal derivatives as antigenic excitants of episodic vertigo.
208. [Pharmaco-pupillometry with methacholine in Ménière's disease].
209. Do musical hallucinations always arise from the inner ear?
210. [Changes in tubal permeability and Ménière's disease].
211. [Effectiveness of sodium bicarbonate (CO3 NaH) therapy of symptoms of Menière's disease, especially vertigo].
212. [Etiopathogenesis and diagnosis of Ménière's disease].
213. Vertigo and Ménière's syndrome.
214. [Diseases associated with Ménière's disease].
215. [The behavior of arterial pressure in patients with Ménière's disease].
216. The role of food allergy in otolaryngology disorders.
217. Benzyl cinnamate in treatment of Ménière's syndrome and tinnitus aurum; a clinical report.
218. The role of labyrinthectomy and cochlear implantation in Menière's disease.
219. The possible roles of hormones and enzymes in the production of the acute attack in Menière's disease.
220. [Otoneurologic problems in the course of Ménière's disease. I].
221. Headache and Menière's disease.
222. Allergy and the refractory otorhinolaryngology patient.
223. [Nursing of patients with vertigo--with special reference to Menière's disease].
224. Symposium: management of Ménière's disease. I. Historical aspects of Ménière's disease (Prosper Ménière).
225. [Meniere's disease and otospongiosis].
226. [Treatment of Menière's disease].
227. [Resection of the tympanic plexus for Meniere's disease and cervical osteochondrosis].
228. Is allergy related to Meniere's disease?
229. [A rare case of simultaneous development of Meniere's disease and glaucoma].
230. Meniere's disease. The inner ear out of balance.
231. Hypoglycemia in Meniere's disease.
232. [Status of the central nervous system in Ménière's syndrome].
233. [Case of traumatic Menière's syndrome with vertical vertigo].
234. Endolymphatic ion concentration in Meniere's disease.
235. Ménière's syndrome.
236. Ménière disease.
237. [Discussion of the paper of Mr. J. van den Branden presented at the meeting of September 26, 1953 entitled: "Menière's vertigo"].
238. [Circulatory disorders in Ménière's disease].
239. Clinical evaluation of antivert in symptoms associated with Ménière's syndrome.
240. Surgical management of vertigo of peripheral origin due to Meniere's disease and other causes.
241. [Allergy and the inner ear].
242. Biochemical studies of inner ear fluid in man. Changes in otosclerosis, Meniere's disease, and acoustic neuroma.
243. The dizzy patient--allergic aspect.
244. Evidence for a Vascular Mechanism in Ménière's Syndrome.
245. "How I do it" - otology and neurotology. A specific issue and its solution. Etiology as a guide in the management of Menière's disease.
246. Ménière's disease.-WRIGHT AJ.
247. Ménière's disease.-HALLPIKE CS.
248. Meniere's disease.-NELSON-JONES A.
249. Ménière's disease.-HARRISON ME.
250. Ménière's disease.-CAWTHORNE T.
251. Ménière's Disease-A Critical Review.
252. [Etiology and classification of Ménière's disease].
253. A fresh clinical look at Meniere's disease.
254. Menière's syndrome.
255. Ménière's syndrome; the basic fault?
256. Ménière's, a synonym of confusion.
257. [A BIBLIOGRAPHY OF FOREIGN LITERATURE TO THE PRESENT DAY ON MENIERE'S DISEASE].
258. Ménière's disease.-LINDSAY JR.
259. [Central processes in Meniere's syndromes].
260. Meniere's disease. Recent advances in basic and clinical aspects. Proceedings of the Satellite Bárány Society Meeting. Taipei, May 22-23, 1990.
261. Immunoglobulin E and circulating immune complexes in endolymphatic hydrops.
262. Symposium on Meniere's disease.
263. Meniere's disease diagnosis and treatment.
264. Meniere's disease.
265. Ménière's disease; a personal experience.
266. [Meniere's disease--new discoveries and posibilities].
267. [Menière's disease].-Jongkees LB.
268. [Menière's disease].-Levshova AS.
269. The history of Meniere's disease.
270. Letters to the editor: diagnosis of Ménière's disease.
271. [Vértigo].
272. The possible roles of hormones and enzymes in the production of the acute attack in Menière's disease.
273. Allergy in otolaryngology.
274. Letter: Endolymphatic hydrops and glaucoma production.
275. [Ménière's disease].
276. [Ménière's syndrome].
277. [Meniere's disease].
278. A note on Menière's syndrome.
279. [Menière's disease].-Kalinovskaia IIa.
280. [Meniere's disease].-Kawada M.
281. Ménière's disease.-Fuller AP.
282. [Ménière's disease].-Waar CA.
283. [Ménière's syndrome].
284. [Experimental reproduction in the cat of "Meniere's" labyrinthosis with chronic evolution].
285. [Meniere's disease: with special reference to recent activities in the Otorhinolaryngology Department at Osaka University].
286. The allergy--part 1.
287. Remarks on Vertigo, and the Group of Symptoms Sometimes Called Menière's Disease.
288. [Menier's disease. Recent acquisitions].
289. Clinical allergy--state of the art.
290. Value of histamine skin tests in Ménière's disease.
291. [Introduction to course in allergy and allergy diagnosis].
292. Labyrinthine Vertigo (Ménière's Symptoms-Non- infective) treated by Operation.
293. Labyrinthine Vertigo (Menière's Symptoms-Non- infective) treated by Operation.
294. Prismatic effect on symptoms of Menière's disease.
295. [On the role of allergy in inflammatory rheumatism and its treatment with streptococcal vaccine via arterial route].
296. [Immunopathologic aspects of recurrent phlebitis and nodular vascularitis. Therapeutic applications].
297. A Case of Acute Ménière's Symptoms in Splenomedullary Leucocythæmia, with Special Reference to the Anatomical Changes found in Acute Leucocythæmic Affections of the Ear: Including a Pathological Report on the Present Case.
298. Nutritional deficiencies: their role in allergy and intolerance.
299. Allergy-immunology. Unproved techniques and theories.
300. Clinical allergy.-Owen RM.
301. Letter: Controversial techniques in allergy.
302. Allergy and otolaryngology.
303. [Role of allergy in the pathogenesis of adhesion disease].
304. Gastro-intestinal Sepsis, a Cause of Ménière's Symptoms.
305. Case with Well-defined and Transitory Ménière's Symptoms; (?) Migraine with Auditory and Vistibular Phenomena.
306. ABLATION OF THE LABYRINTH IN A CASE WITH MENIERE'S SYMPTOMS.
307. GASTRO-INTESTINAL SEPSIS A CAUSE OF MENIERE'S SYMPTOMS.
308. Does allergy protect against cancer?
309. [Psychosomatic approach to allergies].
310. [The nurse and allergy].
311. Diagnosing allergies.
312. The relation of cancer to allergy.
313. [Immunologic aspect of microbial allergy].
314. [Allergies].
315. Role of allergy in clinical medicine. II.

   

 (點擊上方圖片進入王群光自然診所官網)